Федон Линдберг - X-фактор здорового веса. Как добиться естественной стройности, позаботившись о кишечнике

323. Thawani SP, Brannagan TH, Lebwohl B, et al. Risk of neuropathy among 28 232 patients with biopsy-verified Celiac disease. JAMA Neurology 2015. doi:10.1001/jamaneurol. 2015.0475

324. Evans KE, Leeds JS, Morley S et.al. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci 2010; 55: 2999–3004

325. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215–18

326. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356–61

327. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566–72

328. Sultan AA, Tata LJ, Fleming KM, et al. Pregnancy complications and adverse birth outcomes among women with celiac disease. Am J Gastroenterol. 2014;109:1653–1661

329. Fagrådet i Norsk Cøliakiforening. Retningslinjer – cøliaki. 2004

330. Vanuytsel, T; et al. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers 2013. 1 (5): e27321

331. Fasano, A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 91 (1): 151–75

332. Lammers, Karen M.; Lu, Ruliang; Brownley, Julie; Lu, Bao; Gerard, Craig; Thomas, Karen; Rallabhandi, Prasad; Shea-Donohue, Terez; Tamiz, Amir. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008. 135 (1): 194–204.e3

333. Visser, Jeroen; Rozing, Jan; Sapone, Anna; Lammers, Karen; Fasano, Alessio. «Tight Junctions, Intestinal Permeability, and Autoimmunity Celiac Disease and Type 1 Diabetes Paradigms». Annals of the New York Academy of Sciences 2009. 1165: 195–205

334. Fasano, Alessio. «Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer». Physiological Reviews 2011. 91 (1): 151–175

335. Lemmer, HJ; Hamman, JH. Paracellular drug absorption enhancement through tight junction modulation. Expert Opin Drug Deliv 2013. 10 (1): 103–14

336. NRP. A proteinin the gut may explain why some can’t stomach gluten http://www.npr.org/sections/thesalt/2015/12/09/459061317/a-protein-in-the-gut-may-explain-why-some-cant-stomach-gluten?utm_medium=RSS&utm_campaign=food

337. Umberto Volta, Maria Teresa Bardella, Antonino Calabrò, Riccardo Troncone, Gino Roberto Corazza. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014; 12: 85

338. Luca Elli, Federica Branchi, Carolina Tomba, Danilo Villalta, Lorenzo Norsa, Francesca Ferretti, Leda Roncoroni, Maria Teresa Bardella. Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity. World J Gastroenterol. 2015 June 21; 21(23): 7110–7119

339. Umberto Volta, Giacomo Caio, Francesco Tovoli, Roberto De Giorgio. Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness. Cell Mol Immunol. 2013 September; 10(5): 383–392

340. Francesco Sofi, Anne Whittaker, Anna Maria Gori, Francesca Cesari, Elisabetta Surrenti, Rosanna Abbate, Gian Franco Gensini, Stefano Benedettelli, Alessandro Casini. Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial. Br J Nutr. 2014 June 14; 111(11): 1992–1999

341. Norsk Helseinformatikk. FODMAP redusert diett hjelper mot irritabel tarm. http://nhi.no/forside/fodmap-redusert-diett-hjelper-mot-irritabel-tarm-41852.html

342. Halmos, Emma P. et al. A Diet Low in FODMAPs Reduces Symptoms of Irritable bowel Syndrome. Gastroenterology, Volume 146, Issue 1, 67–75.e5 http://gut.bmj.com/content/64/1/93.full.pdf+html

343. Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012 Aug;142(8):1510–8

344. Skodje, G. Norsk tidsskrift for Ernæring. Fodmap: Oversikt og oppdatering. http://www.ntfe.no/utgaver/20-nr-3-2014/142-fodmap-oversikt-og-oppdatering

345. Norsk Helseinformatikk– Dette er FODMAP reduserte matvarer. http://nhi.no/forside/dette-er-fodmap-reduserte-matvarer-41880.html

346. Wathsala S Nanayakkara, Paula ML Skidmore, Leigh O’Brien, Tim J Wilkinson, Richard B Gearry. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016; 9: 131–142

347. Marina Iacovou, Victoria Tan, Jane G Muir, Peter R Gibson. The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil. 2015 October; 21(4): 459–470

348. Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, Stefano Fiorucci. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 2016 February 21; 22(7): 2219–2241

349. Bruno P. Chumpitazi, Julia L. Cope, Emily B. Hollister, Cynthia M. Tsai, Ann R. McMeans, Ruth A. Luna, James Versalovic, Robert J. Shulman. Randomised Clinical Trial: Gut Microbiome Biomarkers are Associated with Clinical Response to a Low FODMAP Diet in Children with Irritable Bowel Syndrome. Aliment Pharmacol Ther. Aliment Pharmacol Ther. 2015 August; 42(4): 418–427

350. Suma Magge, Anthony Lembo. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y) 2012 November; 8(11): 739–745

351. Natalia Pedersen, Zsuzsanna Vegh, Johan Burisch, Lisbeth Jensen, Dorit Vedel Ankersen, Maria Felding, Nynne Nyboe Andersen, Pia Munkholm. Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol. 2014 June 7; 20(21): 6680–6684

352. Louise Maagaard, Dorit V Ankersen, Zsuzsanna Végh, Johan Burisch, Lisbeth Jensen, Natalia Pedersen, Pia Munkholm. World J Gastroenterol. 2016 April 21; 22(15): 4009–4019

353. So Ra Yoon, Jong Hwa Lee, Jae Hyang Lee, Ga Yoon Na, Kyun-Hee Lee, Yoon-Bok Lee, Gu-Hun Jung, Oh Yoen Kim. Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial. Nutr J. 2015; 14: 116

354. Andromanakos NP, Pinis SI, Kostakis AI. Chronic severe constipation: current pathophysiological aspects, new diagnostic approaches, and therapeutic options. European Journal of Gastroenterology & Hepatology. Mar 2015;27(3):204–214

355. Anti M, et al. Water supplementation enhances the effect of high-fiber diet on stool frequenc and laxative consumption in adult patients with functional constipation. Hepato-gastroenterology. May-Jun 1998;45(21):727–732

356. Arora G, Mannalithara A, Mithal A, Triadafilopoulos G, Singh G. Concurrent conditions in patients with chronic constipation: a population-based study. PloS one. 2012;7(10):e42910

357. Ashraf W, Park F, Lof J, Quigley EM. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Alimentary pharmacology & therapeutics. Dec 1995;9(6):639–647

358. Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EM. Constipation in Parkinson’s disease: objective assessment and response to psyllium. Mov Disord. Nov 1997;12(6):946–951

359. Attaluri A, Donahoe R, Valestin J, Brown K, Rao SS. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Alimentary pharmacology & therapeutics. Apr 2011;33(7):822–828

360. Beradze G, Sherozia M, Shankulashvili G. Influence of an exercise therapy on primary chronic constipation. Georgian Med News. Sep 2011(198):29–32

361. Borre M, Qvist N, Raahave D, Worsoe J, JP AE, Christensen P, Krogh K. The effect of lifestyle modification on chronic constipation. Ugeskrift for laeger. Apr 6 2015;177(15)

362. Camilleri M, Bharucha AE. Behavioural and new pharmacological treatments for constipation: getting the balance right. Gut. Sep 2010;59(9):1288–1296

363. Chiba M, Tsuji T, Nakane K, Komatsu M. High amount of dietary fiber not harmful but favorable for Crohn disease. The Permanente journal. Winter 2015;19(1):58-61

364. Chmielewska A, Szajewska H. Systematic review of randomized controlled trials: probiotics for functional constipation. World journal of gastroenterology: WJG. Jan 7 2010;16(1):69–75

365. Choi CH, Chang SK. Alteration of Gut Microbiota and Efficacy of Probiotics in Functional Constipation. Journal of Neurogastroenterology and Motility. 2015;21(1):4–7

366. Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clinical and experimental hypertension (New York, N.Y.: 1993). Aug 2007;29(6):383–394

367. Collado Yurrita L, San Mauro Martin I, Ciudad-Cabanas MJ, Calle-Puron ME, Hernandez Cabria M. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials. Nutr Hosp. 2014;30(2):244–252

368. Dahl WJ, Whiting SJ, Healey A, Zello GA, Hildebrandt SL. Increased stool frequency occurs when finely processed pea hull fiber is added to usual foods consumed by elderly residents in long-term care. Journal of the American Dietetic Association. Sep 2003;103(9):1199–1202

369. Daulatzai MA. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochemical research. Apr 2014; 39(4):624–644

370. De Palma G, Collins SM, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes. May-Jun 2014;5(3):419–429

371. De Schryver AM, Keulemans YC, Peters HP, Akkermans LM, Smout AJ, De Vries WR, van Berge-Henegouwen GP. Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation. Scandinavian Journal of Gastroenterology. Apr 2005;40(4):422–429

372. Dupont C, Campagne A, Constant F. Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. Aug 2014;12(8):1280–1287

373. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. May 2013;108(5):718–727

374. Iovino P, Chiarioni G, Bilancio G, Cirillo M, Mekjavic IB, Pisot R, Ciacci C. New onset of constipation during long-term physical inactivity: a proof-of-concept study on the immobility-induced bowel changes. PloS one. 2013;8(8):e72608

375. Izzo AA, Gaginella TS, Capasso F. The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnesium research: official organ of the International Society for the Development of Research on Magnesium. Jun 1996;9(2):133–138

376. Karhunen LJ, et al. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. The Journal of Nutrition. Apr 2010; 140(4):737–744

377. Khatri PK, Ali AD, Alzadjali N, Bhagia G, Khaliqdina SJ, Aziz S. Frequency of functional constipation in 3 different populations and its causative factors. J Pak Med Assoc. Nov 2011; 61(11):1149–1152